Core Laboratories Inc. (NYSE:CLB – Get Free Report) shares traded up 5.6% on Monday . The company traded as high as $11.69 and last traded at $11.72. 166,235 shares were traded during trading, a decline of 71% from the average session volume of 566,757 shares. The stock had previously closed at $11.10.
Analysts Set New Price Targets
Several equities analysts have recently commented on the company. Wall Street Zen downgraded Core Laboratories from a “hold” rating to a “sell” rating in a research report on Saturday, July 4th. Weiss Ratings cut Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, June 24th. Two investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Core Laboratories has an average rating of “Reduce” and a consensus price target of $12.00.
Read Our Latest Stock Analysis on CLB
Core Laboratories Price Performance
Core Laboratories (NYSE:CLB – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share for the quarter, meeting the consensus estimate of $0.06. The company had revenue of $121.80 million for the quarter, compared to analyst estimates of $122.99 million. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%.Core Laboratories’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.14 EPS. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. On average, equities analysts forecast that Core Laboratories Inc. will post 0.56 EPS for the current fiscal year.
Core Laboratories Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Monday, May 11th were paid a dividend of $0.01 per share. The ex-dividend date was Monday, May 11th. This represents a $0.04 annualized dividend and a dividend yield of 0.3%. Core Laboratories’s dividend payout ratio (DPR) is currently 6.15%.
Hedge Funds Weigh In On Core Laboratories
Several institutional investors have recently bought and sold shares of the business. Summit Securities Group LLC acquired a new position in shares of Core Laboratories during the first quarter worth $31,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of Core Laboratories in the 4th quarter worth $34,000. Quarry LP boosted its position in shares of Core Laboratories by 118.1% in the 3rd quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock worth $36,000 after purchasing an additional 1,599 shares in the last quarter. CWM LLC grew its stake in Core Laboratories by 36.1% during the 4th quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after buying an additional 668 shares during the last quarter. Finally, Hantz Financial Services Inc. grew its stake in Core Laboratories by 124.7% during the 4th quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock worth $51,000 after buying an additional 1,763 shares during the last quarter. 97.81% of the stock is owned by hedge funds and other institutional investors.
Core Laboratories Company Profile
Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.
The company’s portfolio spans two primary service lines: reservoir description and production enhancement.
Further Reading
- Five stocks we like better than Core Laboratories
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
